Life-extending breast cancer drug Enhertu approved for use on NHS in England

A drug that can extend the lives of some breast cancer patients has been approved for use on the NHS in England, according to the BBC.

The medicine, Enhertu, has been shown in clinical studies to give patients an extra seven months to live on average, the BBC reported.

According to the report, the drug has already been prescribed to patients in Scotland for more than two years, where it has been available through the NHS there.

The approval marks a significant step for eligible breast cancer patients in England who will now have access to the treatment through the NHS, the BBC said.

Further details on the specific eligibility criteria for patients and the timeline for the drug's rollout across England were not immediately available.